These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1130944)

  • 1. [Synthesis of pyrimidine-4.5-dicarboximide [(author's transl)]].
    Fickentscher K; Günther E
    Arch Pharm (Weinheim); 1975 Feb; 308(2):118-21. PubMed ID: 1130944
    [No Abstract]   [Full Text] [Related]  

  • 2. SYNTHETIC DERIVATIVES OF ISOQUINOLINE, DICARBOXYLIC ACID IMIDES AND THIOIMIDES AS BIOACTIVE COMPOUNDS.
    Solecka J; Rajnisz A; Postek M; Laudy AE; Szawkalo J; Czarnocki Z
    Acta Pol Pharm; 2016 Sep; 73(5):1181-1189. PubMed ID: 29638058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatile and sustainable synthesis of cyclic imides from dicarboxylic acids and amines by Nb2O5 as a base-tolerant heterogeneous Lewis acid catalyst.
    Ali MA; Siddiki SM; Kon K; Hasegawa J; Shimizu K
    Chemistry; 2014 Oct; 20(44):14256-60. PubMed ID: 25225033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyrido(2,3-d)pyrimidine antibacterial agents. V. Synthesis and reactions of 1H,5H-imidazo(1,2-a)pyrido(2,3-d)pyrimidines (author's transl)].
    Matsumoto J; Minamida A; Minami S
    Yakugaku Zasshi; 1980 Dec; 100(12):1187-93. PubMed ID: 7252775
    [No Abstract]   [Full Text] [Related]  

  • 5. [Derivatives of 3-aminothieno(2,3-d)pyrimidine and of 3-amino(1)benzothieno(2,3-d)pyrimidine (author's transl)].
    Sauter F; Stanetty P; Potuzak H
    Arch Pharm (Weinheim); 1976 Nov; 309(11):914-9. PubMed ID: 1016003
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pyrimidine derivatives and related compounds. XXI. Synthesis and analgetic and antiinflammatory activities of 5-dimethylamino-6-methyl-4-oxodihydropyrimidine derivatives (author's transl)].
    Senda S; Hirota K; Otani O
    Yakugaku Zasshi; 1974 May; 94(5):571-6. PubMed ID: 4472838
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synthesis and reactivity of polarized binding-systems (author's transl)].
    Neidlein R; Bottler R
    Arch Pharm (Weinheim); 1975 May; 308(5):379-84. PubMed ID: 1164166
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the development of drugs in the pyrimidine synthesis (author's transl)].
    Senda S; Fujimura H
    Yakugaku Zasshi; 1981 Nov; 101(11):965-79. PubMed ID: 7045325
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the synthesis of pyrimidine derivatives. III. Synthesis of pyrimido(1,2-c)- and imidazo(1,2-c) quinazoline derivatives (author's transl)].
    Yoshikawa T; Shitago K
    Yakugaku Zasshi; 1974 Apr; 94(4):417-23. PubMed ID: 4472647
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on chloromethacrylonitriles and chloroisobuytronitriles. I. Syntheses of pyrimidine compounds from chloromethacrylonitriles and chloroisobutyronitriles (author's transl)].
    Tsurushima M; Ando Y; Yatani K
    Yakugaku Zasshi; 1973 Oct; 93(10):1274-84. PubMed ID: 4798502
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on pyrazolo(3,4-d)pyrimidine derivatives. XI. On 1-phenyl-1H-pyrazolo(3,4-d)pyrimidine-4-carbonitrile (author's transl)].
    Hayashi E; Higashino T; Suzuki S
    Yakugaku Zasshi; 1978 Jul; 98(7):891-7. PubMed ID: 712551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthesis of pyrrolo(2,3-d)pyrimidines (author's transl)].
    Roth HJ; Eger K
    Arch Pharm (Weinheim); 1975 Apr; 308(4):252-8. PubMed ID: 1130967
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on pyrazolo [3,4-d] pyrimidine derivatives. VIII. On syntheses and anti-tumor activity of 4-amino-1-(o-, m- or p-nitrophenyl) -1H-pyrazolo[3,4-d] pyrimidines and their derivatives (author's transl)].
    Hayashi E; Higashino T; Suzuki S; Kato T; Kohno M; Shinoda H; Mizuno D
    Yakugaku Zasshi; 1977 Dec; 97(12):1328-33. PubMed ID: 609046
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and anxiolytic activity of N-substituted cyclic imides (1R*,2S*,3R*,4S*)-N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,3- bicyclo[2.2.1]heptanedicarboximide (tandospirone) and related compounds.
    Ishizumi K; Kojima A; Antoku F
    Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2288-300. PubMed ID: 1687114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis and antibacterial and antitumoral activity of some methylhydrazonium salts of pyrimidine bases and their analogues (author's transl)].
    Golovinsky E; Karamanov G; Spassovska N; Maneva L; Spassov A
    Pharmazie; 1982 May; 37(5):355-6. PubMed ID: 7111362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of alpha-(quinolinimido)-glutarimide (author's transl)].
    Fickentscher K
    Arch Pharm (Weinheim); 1974 Jun; 307(6):473-6. PubMed ID: 4841525
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of new N-substituted cyclic imides with expected anxiolytic activity. XXI. Derivatives of 1,4-dibromo-dibenzo[e.h]bicyclo[2.2.2]octane-2,3-dicarboximide.
    Kossakowski J; Krawiecka M; Perliński M
    Acta Pol Pharm; 2002; 59(1):37-43. PubMed ID: 12026111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XIII. Derivatives of 1-methoxybicyclo[2.2.2]oct-5-ene-2,3-dicarboximide.
    Kossakowski J; Krawiecka M
    Acta Pol Pharm; 2000 Nov; 57 Suppl():53-6. PubMed ID: 11293265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trisubstituted s-triazolo(1,5-a)pyrimidines (author's transl)].
    Kreutzberger A; Kreutzberger E
    Arch Pharm (Weinheim); 1976 Feb; 309(2):148-55. PubMed ID: 938208
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XI. Derivatives of 7-diphenylmethylenebicyclo[2.2.1]hept-2-ene-5,6-dicarboximide.
    Kossakowski J; Hejchman E
    Acta Pol Pharm; 2000 Nov; 57 Suppl():57-60. PubMed ID: 11293266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.